Posts

Showing posts with the label Leukemia Therapeutics Market Trends

Leukemia Therapeutics Market Advancements to Watch Out For 2026

Leukemia also known as blood cancer hinders ability of an individual to fight infection. It is characterized by formation of tumors in blood-forming tissues including bone marrow. Various type of leukemia include acute lymphoblastic leukemia, acute myeloid leukemia, and chronic lymphocytic leukemia. Fatigue, weight loss, frequent infections and easy bleeding or bruising are some of the symptoms of this disease. Treatment of early leukemia include monitoring and severe leukemia is treated with chemotherapy, followed by radiation and stem-cell transplant. According to Center for Disease Control and Prevention (CDC), in the U.S. around 45,360 people were diagnosed with leukemia in 2013, leading to 23,549 fatalities (13,625 men and 9,924 women). The condition is more prevalent among men than women. Download The PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/528 Leukemia Therapeutics Market On the basis of disease condition, the global leukemia ther...